AIM ImmunoTech (AIM) Return on Assets (2018 - 2024)
Historic Return on Assets for ImmunoTech (AIM) over the last 8 years, with Q3 2024 value amounting to 0.96%.
- ImmunoTech's Return on Assets fell 5800.0% to 0.96% in Q3 2024 from the same period last year, while for Sep 2024 it was 0.96%, marking a year-over-year decrease of 5800.0%. This contributed to the annual value of 1.45% for FY2024, which is N/A changed from last year.
- According to the latest figures from Q3 2024, ImmunoTech's Return on Assets is 0.96%, which was down 5800.0% from 1.39% recorded in Q2 2024.
- ImmunoTech's 5-year Return on Assets high stood at 0.12% for Q1 2020, and its period low was 1.39% during Q2 2024.
- Moreover, its 3-year median value for Return on Assets was 0.66% (2023), whereas its average is 0.67%.
- In the last 5 years, ImmunoTech's Return on Assets plummeted by -3200bps in 2020 and then plummeted by -5800bps in 2024.
- Over the past 3 years, ImmunoTech's Return on Assets (Quarter) stood at 0.19% in 2020, then tumbled by -407bps to 0.94% in 2023, then decreased by -2bps to 0.96% in 2024.
- Its last three reported values are 0.96% in Q3 2024, 1.39% for Q2 2024, and 1.25% during Q1 2024.